Asbestos-related diseases of the lungs and pleura: Uses, trends and management over the last century

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 4, 2007, Pages 356-369

  Becklake, Margaret R ^a,e   Bagatin, E ^b,c   Neder, J A ^d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Faculty of Medicine of Jundiai   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Asbestos; Diseases of the lung and pleura; Industrialised and less industrialised countries; Trends in disease

Indexed keywords

AMOSITE; AMPHIBOLE; ASBESTOS; CHRYSOTILE;

ASBESTOSIS; ATELECTASIS; CLINICAL FEATURE; DIAGNOSTIC TEST; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INCIDENCE; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; MESOTHELIOMA; MINING; MORTALITY; OCCUPATIONAL EXPOSURE; PLEURA DISEASE; PLEURA EFFUSION; PLEURA PLAQUE; PRIORITY JOURNAL; REVIEW; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; WORKPLACE;

ASBESTOSIS; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MINERAL FIBERS; PLEURAL DISEASES; WORKPLACE;

EID: 34247158183     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Lesage M. ILO international classification of radiographs of pneumoconioses. In: Stellman J M, ed. International Labour Office. Encyclopaedia of occupational health and safety. 4th ed. Part II. Respiratory system. Geneva, Switzerland: ILO, 1997: pp 10.33-10.38.
2. Liddell D, Miller K. Mineral fibres and health. Boca Raton, FL, USA: CRC Press, 1991: p 381.
3. Selikoff I, Lee D H K. Asbestos and disease. New York, NY, USA: New York Academic Press, 1978: p 549.
4. Rom W N. Asbestos related diseases. In: Rom W N, ed. Environmental and occupational medicine. 3rd ed. Philadelphia, PA, USA: Lippincott-Raven, 1998: 349-376.
5. Cowie R L, Murray J, Becklake M R. Pneumoconioses. Chapter 61. In: Mason R J, Broaddus V C, Murray J T, Nadel J A, eds. Murray and Nadel's textbook of respiratory medicine, 4th ed. Vol. 2. Philadelphia, PA, USA: Elsevier Saunders, 2005: pp 1748-1782.
6. De Vuyst P, Gevenois P A. Asbestosis. In: Hendrick D J, Burge P S, Beckett W S, Churg A, eds. Occupational disorders of the lung: recognition, management and prevention. Edinburgh, UK: WB Saunders, Elsevier Science, 2002: p 144.
7. Copes R, Thomas D, Becklake M R. Temporal patterns of exposure and nonmalignant pulmonary abnormality in Quebec chrysotile workers. Arch Environ Health 1985; 40: 80-87.
8. Craighead J E, Abraham J L, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982; 106: 544-596.
9. Becklake M R. Asbestos criteria. [Letter to the editor] Arch Pathol Lab Med 1984; 108: 93.
10. De Vuyst P, Jedwab J, Dumortier P, et al. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 1982; 126: 972-976.
11. Case B W, Sebastien P. Environmental and occupational exposures to chrysotile asbestos: a comparative microanalytic study. Arch Environ Health 1987; 42: 185-191.
12. McDonald J C, Becklake M R, Fournier-Massey G, Rossiter C E. Respiratory symptoms in chrysotile asbestos mine and mill workers of Quebec. Arch Environ Health 1972; 24: 358-363.
13. Brodkin C A, Barnhart S, Anderson G, Checkoway H, Omenn G S, Rosenstock L. Correlation between respiratory symptoms and pulmonary function in asbestos-exposed workers. Am Rev Respir Dis 1993; 148: 32-37.
14. Ross R. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest 2003; 124: 1120-1128.
15. Mukherjee A K, Rajmohan H R, Dave S K, Rajan B K, Kakde Y, Rao S R. An environmental survey in chrysotile asbestos milling processes in India. Am J Ind Med 1992; 22: 543-551.
16. Mukherjee S, de Klerk N, Palmer L J, Olsen N J, Pang S C, Musk A W. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med 2000; 162: 1807-1811.
17. International Labour Office. International classification of radiographs of pneumonconiosis. Geneva, Switzerland: ILO, 2003.
18. Lilis R, Miller A, Godbold J, Chan E, Selikoff I J. Radiographic abnormalities in asbestos insulators: effects of duration from onset of exposure and smoking. Relationships of dyspnea with parenchymal and pleural fibrosis. Am J Ind Med 1991; 20: 1-15.
19. Miller A, Lilis R, Godbold J, Wu X. Relation of spirometric function to radiographic interstitial fibrosis in two large work-forces exposed to asbestos: an evaluation of the ILO profusion score. Occup Environ Med 1996; 53: 808-812.
20. Lee Y C, Singh B, Pang S C, de Klerk N H, Hillman D R, Musk A W. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med 2003; 60: 201-206.
21. Gevenois P A, De Vuyst P, Dedeire S, Cosaerte J, Van de Weyer R, Sturyven J. Conventional and high-resolution CT in asymptomatic asbestos exposed workers. Acta Radiol 1994; 35: 226-229.
22. Harkin T J, McGuinness G, Goldring R, et al. Differentiation of the ILO boundary chest roentgenograph (0/1 to 1/0) in asbestosis by high-resolution computed tomography scan, alveolitis, and respiratory impairment. J Occup Environ Med 1996; 38: 46-52.
23. Neri S, Boraschi P, Antonelli A, Falaschi F, Baschieri L. Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med 1996; 30: 588-595.
24. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004; 170: 691-715.
25. Lynch D A, Gamsu G, Aberle D R. Conventional and high resolution computed tomography in the diagnosis of asbestosrelated diseases. Radiographics 1989; 9: 523-551.
26. Copley S, Hansell D M. Imaging. In: Hendrick D J, Burge P S, Beckett W S, Churg A, eds. Occupational disorders of the lung: recognition, management and prevention. Edinburgh, UK: WB Saunders, Elsevier Science, 2002: pp 483-502.
27. Teschler H, Friedrichs K H, Hoheisel G B, et al. Asbestos fibers in bronchoalveolar lavage and lung tissue of former asbestos workers. Am J Respir Crit Care Med 1994; 149: 641-645.
28. Churg A. Non neoplastic induced asbestos-related disease. In: Churg A, Green F H Y, eds. Pathology of occupational lung disease. 2nd ed. Baltimore, MD, USA: Williams and Wilkins, 1998: pp 277-338.
29. Becklake M R. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140 (Suppl): S85-S91.
30. Sette A, Neder J A, Nery L E, et al. Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos. Radiology 2004; 232: 66-74.
31. Shih J F, Wilson J S, Broderick A, et al. Asbestos-induced pleural fibrosis and impaired exercise physiology. Chest 1994; 105: 1370-1376.
32. Cugell D W, Kamp D W. Asbestos and the pleura: a review. Chest 2004; 125: 1103-1117.
33. Kee S T, Gamsu G, Blanc P. Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening. Am J Respir Crit Care Med 1996; 154: 789-793.
34. Bourbeau J, Ernst P, Chrome J, Amstrong B, Becklake M R. Relationship between respiratory impairment and asbestos-related pleural abnormality in an active workforce. Am Rev Respir Dis 1990; 142: 837-842.
35. Churg A. Neoplastic induced asbestos-related disease. In: Churg A, Green F H Y, eds. Pathology of occupational lung disease. 2nd ed. Baltimore, MD, USA: Williams and Wilkins, 1998: pp 339-391.
36. Gong M N, Christiani D. Lung cancer. In: Hendrick D J, Burge P S, Beckett W S, Churg A, eds. Occupational disorders of the lung: recognition, management and prevention. Edinburgh, UK: WB Saunders, Elsevier Science, 2002: pp 305-326.
37. Hodgson J T, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44: 565-601.
38. Peto J, Hodgson J T, Matthews F E, Jones J R. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535-539.
39. Peto J, Decarli A, La Vecchia C, Levi F, Negri A. The European mesothelioma epidemic. Br J Cancer 1999; 79: 666-672.
40. Kjaergaard J, Andersson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scan J Work Environ Health 2000; 26: 112-117.
41. Hemminki K, Xinjun L, Mesothelioma incidence seems to have leveled off in Sweden. Int J Cancer 2003; 103: 145-46.
42. Ulvestad B, Kjaerheim K, Moller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003; 107: 94-98.
43. Montanaro F, Bray F, Gennaro V, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003; 14: 791-803.
44. Leigh J. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 2003; 9: 206-217.
45. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E. The mesothelioma epidemic in Western Europe: an update. Br J Cancer 2004; 90: 1022-1024.
46. Weill H, Hughes J M, Churg A M. Changing trends in US mesothelioma incidence. Occup Environ Med 2004; 61: 438-441.
47. Kazen-Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer 2005; 49S1: S3-S8.
48. Tossavainen A, Kovalevsky E, Vanhala E, Tuomi T. Pulmonary mineral fibers after occupational and environmental exposure to asbestos in the Russian chrysotile industry. Am J Ind Med 2000; 37: 327-333.
49. Kashansky S V. Prevalence of mesothelioma in various sites in Russia: differences in the exploitation of asbestos fibre types and in the products manufactured. [Abstract] Presented at the International Conference on Chrysotile. Montreal, QC, Canada: Chrysotile Institute, May 23-24, 2006.
50. Tossavainen A, Kotilainen M, Takahashi K, Pan G, Vanhala E. Amphibole fibres in Chinese chrysotile asbestos. Ann Occup Hyg 2001; 45: 145-152.
51. Liu X, Luo S, Wang Z, et al. An investigation of crocidolite contamination and mesothelioma in a rural area of China. Biomed Environ Sci 1990; 3: 156-165.
52. Luo S O, Mu S H, Zhan C. A retrospective cohort study (1987-1995) of malignant neoplasm in a country contaminated with crocidolite. Chin J Ind Hyg Occup Dis 1997; 15: 272-276.
53. Zhou Y, Luo S, Song Y, et al. A clinical-pathologic analisis of 47 cases of mesothelioma resulted from environmental exposure to crocidolite. Chin J Ind Hyg Occup Dis 1998; 16: 169-170. [Chinese]
54. Luo S, Liu X, Mu S, Tsai S P, Wen C P. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med 2003; 60: 35-42.
55. Bagatin E, Neder J A, Nery L E, et al. Non-malignant consequences of decreasing asbestos exposure in the Brazil chrysotile mines and mills. Occup Environ Med 2005; 62: 381-389.
56. Algranti E, Mendonca E M, DeCapitani E M, Freitas J B, Silva H C, Bussacos M A. Non-malignant asbestos-related diseases in Brazilian asbestos-cement workers. Am J Ind Med 2001; 40: 240-254.
57. Pinheiro G A, Antao V C, Monteiro M M, Capelozzi V L, Terra-Filho M. Mortality from pleural mesothelioma in Rio de Janeiro, Brazil, 1979-2000: estimation from death certificates, hospital records, and histopathologic assessments. Int J Occup Environ Health 2003; 9: 147-152.
58. McCulloch J. Asbestos blues: labour, capital, physicians and the state in South Africa. Bloomington, IN, USA: James Currey and Indiana University Press, 2002.
59. Wagner J C, Sleggs C A, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North-Western Cape province. Br J Ind Med 1960; 17: 260-271.
60. Zwi A B, Reid G, Landau S P, Kielkowski D, Sitas F, Becklake M R. Mesothelioma in South Africa, 1976-84: incidence and case characteristics. Int J Epidemiol 1989; 18: 320-329.
61. Sluis-Cremer G K, Liddell F D, Logan W P, Bezuidenhout B N. The mortality of amphibole miners in South Africa, 1946-80. Br J Ind Med 1992; 49: 566-575.
62. Kielkowski D, Nelson G, Rees D. Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study. Occup Environ Med 2000; 57: 563-567.
63. Mutetwa B. Chrysotile asbestos and asbestos in Zimbabwe. Presented at the International Conference on Chrysotile. Montréal, QC, Canada: Chrysotile Institute, May 23-24, 2006.
64. Szeszenia-Dabrowska N. Environmental exposure to asbestos in asbestos cement workers: a case of additional exposure from indiscriminate use of industrial wastes. Int J Occup Med Environ Health 1998; 11: 171-177.
65. Gaafar R M, Eldin N H A. Epidemic of mesothelioma in Egypt. Lung Cancer 2005; 49 (Suppl 1): S17-S20.
66. Emri S, Demir A U. Malignant pleural mesothelioma in Turkey, 2000-2002. Lung Cancer 2004; 45 (Suppl 1): S17-S20.
67. Joshi T K, Gupta R K. Asbestos in developing countties: magnitude of risk and its practical implications. Int J Occup Med Environ Health 2004; 17: 179-185.
68. Murlidhar V, Kanhere V. Asbestosis in an asbestos composite mill at Mumbai: a prevalence study. Environ Health 2005; 4: 1-7.
69. Dutta M, Sreedhar R, Basu A. The blighted hills of Roro, Jharkhand, India: a tale of corporate greed and abandonment. Int J Occup Environ Health 2003; 9: 254-259.
70. Cartheman B. 'Controlled use' of asbestos. Int J Occup Environ Health 2003; 9: 294-298.